85 related articles for article (PubMed ID: 23202532)
21. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
Rosen HR; Shackleton CR; Higa L; Gralnek IM; Farmer DA; McDiarmid SV; Holt C; Lewin KJ; Busuttil RW; Martin P
Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061
[TBL] [Abstract][Full Text] [Related]
22. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
[TBL] [Abstract][Full Text] [Related]
23. Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy.
Manousou P; Samonakis D; Cholongitas E; Patch D; O'Beirne J; Dhillon AP; Rolles K; McCormick A; Hayes P; Burroughs AK
Liver Transpl; 2009 Dec; 15(12):1783-91. PubMed ID: 19938143
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis C virus (HCV)-related cryoglobulinemia after liver transplantation for HCV cirrhosis.
Duvoux C; Tran Ngoc A; Intrator L; Hézode C; Germanidis G; Pawlotsky JM; Cherqui D; Dhumeaux D
Transpl Int; 2002 Jan; 15(1):3-9. PubMed ID: 11875606
[TBL] [Abstract][Full Text] [Related]
25. Outcome of living donor liver transplantation for Egyptian patients with hepatitis C (genotype 4)-related cirrhosis.
Yosry A; Esmat G; El-Serafy M; Omar A; Doss W; Said M; Abdel-Bary A; Hosny A; Marawan I; El-Malt O; Kamel RR; Hatata Y; Ghali A; Sabri H; Kamel S; El-Gbaly H; Tanaka K
Transplant Proc; 2008 Jun; 40(5):1481-4. PubMed ID: 18589133
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis C-induced hepatic allograft injury is associated with a pretransplantation elevated viral replication rate.
Pelletier SJ; Raymond DP; Crabtree TD; Berg CL; Iezzoni JC; Hahn YS; Sawyer RG; Pruett TL
Hepatology; 2000 Aug; 32(2):418-26. PubMed ID: 10915752
[TBL] [Abstract][Full Text] [Related]
27. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.
Burra P; Loreno M; Russo FP; Germani G; Galligioni A; Senzolo M; Cillo U; Zanus G; Fagiuoli S; Rugge M
Liver Transpl; 2009 Jun; 15(6):619-28. PubMed ID: 19479805
[TBL] [Abstract][Full Text] [Related]
28. Use of liver grafts from donation after cardiac death donors for recipients with hepatitis C virus.
Taner CB; Bulatao IG; Keaveny AP; Willingham DL; Pungpapong S; Perry DK; Rosser BG; Harnois DM; Aranda-Michel J; Nguyen JH
Liver Transpl; 2011 Jun; 17(6):641-9. PubMed ID: 21618684
[TBL] [Abstract][Full Text] [Related]
29. Recurrent hepatitis C virus infection after liver transplantation--long-term follow-up with respect to the HCV genotypes/subtypes.
Arnold JC; Töx U; Goeser T; Otto G; Müller HM; Hofmann WJ; Stremmel W; Theilmann L
Z Gastroenterol; 1997 Apr; 35(4):255-61. PubMed ID: 9163889
[TBL] [Abstract][Full Text] [Related]
30. Histological and clinical outcome after liver transplantation for hepatitis C.
Shuhart MC; Bronner MP; Gretch DR; Thomassen LV; Wartelle CF; Tateyama H; Emerson SS; Perkins JD; Carithers RL
Hepatology; 1997 Dec; 26(6):1646-52. PubMed ID: 9398011
[TBL] [Abstract][Full Text] [Related]
31. Progression of liver fibrosis in patients with chronic hepatitis C after orthotopic liver transplantation.
Chopra KB; Demetris AJ; Blakolmer K; Dvorchik I; Laskus T; Wang LF; Araya VR; Dodson F; Fung JJ; Rakela J; Vargas HE
Transplantation; 2003 Nov; 76(10):1487-91. PubMed ID: 14657691
[TBL] [Abstract][Full Text] [Related]
32. Cirrhosis of mixed etiology (hepatitis C virus and alcohol): Posttransplantation outcome-Comparison with hepatitis C virus-related cirrhosis and alcoholic-related cirrhosis.
Aguilera V; Berenguer M; Rubín A; San-Juan F; Rayón JM; Prieto M; Mir J
Liver Transpl; 2009 Jan; 15(1):79-87. PubMed ID: 19109849
[TBL] [Abstract][Full Text] [Related]
33. Severe recurrent hepatitis C after liver retransplantation for hepatitis C virus-related graft cirrhosis.
Berenguer M; Prieto M; Palau A; Rayón JM; Carrasco D; Juan FS; López-Labrador FX; Moreno R; Mir J; Berenguer J
Liver Transpl; 2003 Mar; 9(3):228-35. PubMed ID: 12619018
[TBL] [Abstract][Full Text] [Related]
34. Methylenetetrahydrofolate reductase C677T polymorphism and liver fibrosis progression in patients with recurrent hepatitis C.
Toniutto P; Fabris C; Falleti E; Cussigh A; Fontanini E; Bitetto D; Fornasiere E; Minisini R; De Feo T; Marangoni F; Pirisi M
Liver Int; 2008 Feb; 28(2):257-63. PubMed ID: 17900242
[TBL] [Abstract][Full Text] [Related]
35. [Long-term consequences of co-infection by hepatitis G virus in hepatitis c virus infected kidney transplant patients].
Rostaing L; Izopet J; Arnaud C; Rumeau JL; Duffaut M; Cisterne JM; Durand D
Nephrologie; 1999; 20(3):165-70. PubMed ID: 10418007
[TBL] [Abstract][Full Text] [Related]
36. Detection of HCV antigens in liver graft: relevance to the management of recurrent post-liver transplant hepatitis C.
Grassi A; Quarneti C; Ravaioli M; Bianchini F; Susca M; D'Errico A; Piscaglia F; Tamè MR; Andreone P; Grazi G; Galli S; Zauli D; Pinna AD; Bianchi FB; Ballardini G
Liver Transpl; 2006 Nov; 12(11):1673-81. PubMed ID: 17031825
[TBL] [Abstract][Full Text] [Related]
37. One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection.
Firpi RJ; Abdelmalek MF; Soldevila-Pico C; Cabrera R; Shuster JJ; Theriaque D; Reed AI; Hemming AW; Liu C; Crawford JM; Nelson DR
Liver Transpl; 2004 Oct; 10(10):1240-7. PubMed ID: 15376304
[TBL] [Abstract][Full Text] [Related]
38. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
[TBL] [Abstract][Full Text] [Related]
39. Association of functional gene polymorphisms of matrix metalloproteinase (MMP)-1, MMP-3 and MMP-9 with the progression of chronic liver disease.
Okamoto K; Mimura K; Murawaki Y; Yuasa I
J Gastroenterol Hepatol; 2005 Jul; 20(7):1102-8. PubMed ID: 15955221
[TBL] [Abstract][Full Text] [Related]
40. Delayed onset of severe hepatitis C-related liver damage following liver transplantation: a matter of concern?
Berenguer M; Aguilera V; Prieto M; Carrasco D; Rayón M; San Juan F; Landaverde C; Mir J; Berenguer J
Liver Transpl; 2003 Nov; 9(11):1152-8. PubMed ID: 14586875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]